FLT3 mutations are the most prevalent genetic aberrations discovered in acute myeloid leukemia (AML), accounting for 30% and represent a high potential of relapse and poor prognosis (Mrózek et al., 2007; Kennedy and Smith, 2020). The gene discussed is FLT3; the disease is acute myeloid leukemia.